Infant Acute Respiratory Distress Syndrome
Watchlist
Retrieved
2021-01-23
Source
Trials
—
Genes
SFTPB,
NKX2-1,
SFTPC,
ABCA3,
TNNT2,
MEGF10,
SFTPA2,
FBN1,
SFTPA1,
TRAF7,
RSPH3,
TRIP4,
MYH3,
TRNT,
HYMAI,
SLC27A4,
MTM1,
ZC4H2,
LAMB2,
ITGA3,
SBDS,
ASCC1,
CUL7,
NPHS1,
CFAP300,
DPM2,
RUNX2,
SNRPB,
SOX9,
ALDH7A1
SFTPB,
NKX2-1,
SFTPC,
ABCA3,
TNNT2,
MEGF10,
SFTPA2,
FBN1,
SFTPA1,
TRAF7,
RSPH3,
TRIP4,
MYH3,
TRNT,
HYMAI,
SLC27A4,
MTM1,
ZC4H2,
LAMB2,
ITGA3,
SBDS,
ASCC1,
CUL7,
NPHS1,
CFAP300,
DPM2,
RUNX2,
SNRPB,
SOX9,
ALDH7A1,
SRP54,
RYR1,
PLAGL1,
KAT6A,
UBE3B,
PIH1D3,
CHRNG,
COLQ,
DNAJC21,
PLEC,
SFTPD,
ACE,
IL10,
IL6,
PRPH2,
NOS3,
IL1B,
SCGB1A1,
IL1A,
CENPJ,
TGFB1,
ITM2B,
VEGFA,
CNMD,
PLA2G2A,
REN,
ABCA4,
RSPH1,
ROM1,
SCNN1A,
MBL2,
PRPH,
MIR34A,
HMOX1,
TNF,
NR3C1,
TST,
LINC01672,
TLR2,
VDR,
GSTK1,
TLR4,
MALAT1,
TTN,
SOD2-OT1,
NPSR1,
MIR431,
MIR200A,
MIR216A,
AIMP2,
TTF1,
MIR26B,
RNF19A,
HCA1,
ADIPOQ,
POLDIP2,
AHSA1,
HPGDS,
MBL3P,
ROCK2,
TREM1,
PCYT1B,
PARPBP,
GRAP2,
CHPT1,
CCDC26,
PTBP2,
LPCAT1,
RAMAC,
PHF5A,
UCN3,
BHLHE40,
PLA2G10,
CYGB,
PLA2G6,
SLCO6A1,
RHO,
TGM2,
EDN1,
CST3,
CCN2,
CTNNB1,
CYP1A2,
CYP3A7,
CYP3A5,
ELANE,
CRK,
SERPINB1,
EPO,
F3,
FGF7,
FGFR4,
FN1,
MAPK14,
ATF2,
TAPBP,
ATD,
ADCY9,
AGT,
AGTR1,
AKT1,
ARSD,
SERPINC1,
ATM,
CLTA,
BCL2,
BMP7,
CA11,
CASP3,
CAT,
CD80,
FUSE,
GATA6,
GDNF,
RAD1,
PLA2G1B,
SRGN,
MAPK1,
PROS2P,
PTBP1,
PTPRC,
RAB27A,
GLRX,
ROCK1,
SLC22A4,
SOD1,
SOD2,
SOD3,
AURKA,
SERPINA1,
SERPINE1,
NOS1,
MMP9,
MIF,
KCNJ13,
IL18,
CXCL8,
IL4,
TNC,
NDST1,
HSPA1B,
HSPA1A,
FOXA2,
HMGB1,
GUCY2D,
GSK3B,
RN7SL263P
Drugs
Aviptadil,
Dipalmitoylphosphatidylcholine, 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoglycerol, sodium salt, synthetic surfactant protein C analogue and synthetic surfactant protein B analogue,
Drotrecogin alfa (activated)
Aviptadil,
Dipalmitoylphosphatidylcholine, 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoglycerol, sodium salt, synthetic surfactant protein C analogue and synthetic surfactant protein B analogue,
Drotrecogin alfa (activated),
Interferon beta,
Lucinactant,
Pulmonary surfactant replacement, porcine
(
CUROSURF
),
Sinapultide, dipalmitoylphosphatidylcholine, palmitoyloleoylphosphatidylglycerol and palmitic acid,
Surface active extract of saline lavage of bovine lungs
(
INFASURF
)
Registered!
Infant acute respiratory distress syndrome is a lung disorder that affects premature infants caused by developmental insufficiency of surfactant production and structural immaturity of the lungs. The symptoms usually appear shortly after birth and may include tachypnea, tachycardia, chest wall retractions (recession), expiratory grunting, nasal flaring and cyanosis during breathing efforts.